Biotech | March 23, 2022
GMP certification for Exothera further extends its viral vector manufacturing capacity
The expansion makes Exothera one of the largest viral vector facilities in Europe
The expansion makes Exothera one of the largest viral vector facilities in Europe
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Data published in the prestigious journal ACS Central Science of the American Chemical Society
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Successful proposals will secure fully funded postdoctoral research positions
Subscribe To Our Newsletter & Stay Updated
